City

Clinical trials near Herlev, Denmark

Active studies with a listed research site in Herlev, Denmark.

14active studies

8recruiting now

23countries represented

146largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Obesity, OverweightCondition

NNC0487-0111, Placebo (matched to NNC0487-0111)Treatment

Australia, Bulgaria81 locations

Novo Nordisk A/SSponsor

Updated 2026-08-17 · NCT07509307See eligibility →

Recruiting nowPhase 3

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Obesity, Knee Osteoarthritis (OA)Condition

NNC0487-0111, Placebo (matched to NNC0487-0111 )Treatment

Australia, Bulgaria82 locations

Novo Nordisk A/SSponsor

Updated 2026-07-09 · NCT07481630See eligibility →

Recruiting nowNot applicable

When to INDuce for OverWeight? (WINDOW)

Pregnancy, ObesityCondition

Elective induction of labor at 39 gestational weeks and 0 to 3 daysTreatment

Denmark12 locations

University of AarhusSponsor

Updated 2026-06-26 · NCT04603859See eligibility →

Recruiting nowPhase 4

A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease

Chronic Kidney Disease(CKD)Condition

Dapagliflozin, SemaglutideTreatment

Denmark, Germany4 locations

Peter RossingSponsor

Updated 2025-11-20 · NCT07239570See eligibility →

Recruiting nowPhase 1

The Role of the Amylin Analogue Cagrilintide in Bone Metabolism

ObesityCondition

Cagrilintide, SemaglutideTreatment

Denmark1 locations

Novo Nordisk A/SSponsor

Updated 2025-07-25 · NCT07010432See eligibility →

Recruiting nowPhase 4

The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease

Coronary Artery Disease, Coronary Microvascular DysfunctionCondition

Tirzepatide, PlaceboTreatment

Denmark3 locations

Tina VilsbøllSponsor

Updated 2025-05-22 · NCT06606821See eligibility →

Recruiting nowPhase 2

Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis

Osteoarthritis in the Knee, ObesityCondition

KBP-336, PlaceboTreatment

Czechia, Denmark20 locations

KeyBioscience AGSponsor

Updated 2025-02-19 · NCT06833749See eligibility →

Recruiting nowPhase 3

Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes

Cardiovascular Diseases, Heart FailureCondition

Aspirin tablet, SemaglutideTreatment

Denmark2 locations

Steno Diabetes Center CopenhagenSponsor

Updated 2025-01-10 · NCT06082063See eligibility →

Opening soonPhase 3

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Obesity or Overweight, Weight-Related ComorbidityCondition

AZD6234, PlaceboTreatment

Argentina, Brazil88 locations

AstraZenecaSponsor

Updated 2026-08-20 · NCT07776509See eligibility →

Invitation onlyPhase 4

Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study

Type 2 DM, Type 2 DM /Diabetic NephropathyCondition

Semaglutide, 1.34 mg/mL, Finerenone Oral TabletTreatment

Denmark1 locations

Steno Diabetes Center CopenhagenSponsor

Updated 2025-12-22 · NCT06954090See eligibility →

Active, not recruitingPhase 3

A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight

Type 1 Diabetes, ObesityCondition

Tirzepatide, PlaceboTreatment

Argentina, Brazil146 locations

Eli Lilly and CompanySponsor

Updated 2026-05-12 · NCT06914895See eligibility →

Active, not recruitingNot applicable

Healthy Lifestyle Before and During Pregnancy to Prevent Childhood Obesity - the PRE-STORK-trial

Overweight and Obesity, Pregnancy RelatedCondition

Diet, ExerciseTreatment

Denmark1 locations

Steno Diabetes Center CopenhagenSponsor

Updated 2026-04-16 · NCT05578690See eligibility →

Active, not recruitingPhase 2

A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy

Diabetes Mellitus, Type 2, Diabetic Peripheral NeuropathyCondition

CagriSema (Cagrilintide B and Semaglutide I), Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)Treatment

Canada, Denmark54 locations

Novo Nordisk A/SSponsor

Updated 2025-12-05 · NCT06797869See eligibility →

Active, not recruitingNot applicable

Hedonic and Homeostatic Appetite Control in Obesity and Type 2 Diabetes in the Context of Meal and Exercise Timing

Overweight and Obesity, Type 2 DiabetesCondition

Exercise, ControlTreatment

Denmark1 locations

Steno Diabetes Center CopenhagenSponsor

Updated 2025-05-30 · NCT05768958See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Herlev, Denmark

Current studies

Related cities